» Articles » PMID: 36358919

Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Nov 11
PMID 36358919
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is a critical cellular adaptive response in tumor formation. Nutritional deficiency and hypoxia exacerbate autophagic flux in established malignancies, promoting tumor cell proliferation, migration, metastasis, and resistance to therapeutic interventions. Pro-survival autophagy inhibition may be a promising treatment option for advanced cancer. Furthermore, excessive or persistent autophagy is cytotoxic, resulting in tumor cell death. Targeted autophagy activation has also shown significant promise in the fight against tumor drug resistance. Several research groups have examined the ability of natural products (NPs) such as alkaloids, terpenoids, polyphenols, and anthraquinones to serve as autophagy inhibitors or activators. The data support the capacity of NPs that promote lethal autophagy or inhibit pro-survival autophagy from being employed against tumor drug resistance. This paper discusses the potential applications of NPs that regulate autophagy in the fight against tumor drug resistance, some limitations of the current studies, and future research needs and priorities.

Citing Articles

Cytotoxic Activity of Curcumin- and Resveratrol-Loaded Core-Shell Systems in Resistant and Sensitive Human Ovarian Cancer Cells.

Wezgowiec J, Lapinska Z, Lamch L, Szewczyk A, Saczko J, Kulbacka J Int J Mol Sci. 2025; 26(1.

PMID: 39795900 PMC: 11720041. DOI: 10.3390/ijms26010041.


Natural autophagy modulators in non-communicable diseases: from autophagy mechanisms to therapeutic potential.

Xu T, Deng Y, Yu X, Li M, Fu Y Acta Pharmacol Sin. 2024; 46(1):8-32.

PMID: 39090393 PMC: 11697321. DOI: 10.1038/s41401-024-01356-y.


Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin-The Crucial Limitation or Potential Therapeutic Target?.

Katanic Stankovic J, Selakovic D, Rosic G Int J Mol Sci. 2023; 24(19).

PMID: 37834021 PMC: 10572959. DOI: 10.3390/ijms241914574.


Lenvatinib resistance mechanism and potential ways to conquer.

Bo W, Chen Y Front Pharmacol. 2023; 14:1153991.

PMID: 37153782 PMC: 10157404. DOI: 10.3389/fphar.2023.1153991.


The Role of Autophagy and Apoptosis in the Combined Action of Plasma-Treated Saline, Doxorubicin, and Medroxyprogesterone Acetate on K562 Myeloid Leukaemia Cells.

Pavlik T, Gudkova V, Razvolyaeva D, Pavlova M, Kostukova N, Miloykovich L Int J Mol Sci. 2023; 24(6).

PMID: 36982174 PMC: 10049101. DOI: 10.3390/ijms24065100.


References
1.
Zhou Y, Yu Y, Lv H, Zhang H, Liang T, Zhou G . Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent. Food Chem Toxicol. 2022; 168:113385. DOI: 10.1016/j.fct.2022.113385. View

2.
Wang H, Wang H, Ge L, Zhao Y, Zhu K, Chen Z . Betulinic acid targets drug-resistant human gastric cancer cells by inducing autophagic cell death, suppresses cell migration and invasion, and modulates the ERK/MEK signaling pathway. Acta Biochim Pol. 2021; 69(1):25-30. DOI: 10.18388/abp.2020_5530. View

3.
Rosenfeld M, Ye X, Supko J, Desideri S, Grossman S, Brem S . A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 2014; 10(8):1359-68. PMC: 4203513. DOI: 10.4161/auto.28984. View

4.
Khan M, Bouyahya A, Hachlafi N, El Menyiy N, Akram M, Sultana S . Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations. Environ Sci Pollut Res Int. 2022; 29(17):24411-24444. DOI: 10.1007/s11356-021-17795-7. View

5.
Gor R, Sampath S, Lazer L, Ramalingam S . RNA binding protein PUM1 promotes colon cancer cell proliferation and migration. Int J Biol Macromol. 2021; 174:549-561. DOI: 10.1016/j.ijbiomac.2021.01.154. View